North America’s Clinical Nutrition Market – Growth, Trends and Forecast (2019-2024) – – Yahoo Finance

DUBLIN–(BUSINESS WIRE)–’s offering.” data-reactid=”12″>The “North America Clinical Nutrition Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to’s offering.

The North American clinical nutrition market is well-established, owing to multiple factors contributing to the growth. Some of the primary factors include a large geriatric population base, the growing burden of chronic diseases, and increased awareness in the society regarding clinical nutrition.

Recent years have observed high focus by the companies and hospitals, toward health and wellness, aging, and disease prevention. For a number of chronic diseases, such as coronary artery disease, ischemic stroke, diabetes, diabetes, and few cancer indications, preventive medical nutrition is effective and steadily being adopted by hospitals and clinics in North America.

Moreover, healthcare expenditure continues to grow faster than economic growth in most countries. The presence of equitable, responsive, and efficient health systems across North American countries has also contributed to the maximum share of GDP, for healthcare expenditure. Such factors drive the demand for clinical nutrition in North America.

In terms of route of administration of clinical nutrition to the patients, oral and enteral routes are mostly preferred for a large number of diseases for a significant period of disease treatment. As long as the patients can consume food orally, their stomach and intestine functionalities are not affected, the oral route is the preferred route of administration for clinical nutrition.

There are several types of formulations for enteral nutrition, which are preferred based on the complexity of diseases by physicians and doctors, such as liquid solution, soluble tablets, dispersible tablets, and capsules, among others.

In several cases, patients suffering from the trauma of mouth and throat, and few cancers of the GI tract, like mouth cancer, throat cancer, etc., the preferred route of administration is enteral. However, the initial cost of set-up is high for such facilities, which limit the growth of this segment to some extent. As several well-established companies have good distribution model across the North America region, this offsets the barriers linked to this segment.

There are several international major players, as well as domestic companies in the United States, Canada, and Mexico, which creates a good competitive scenario for companies in the North American clinical nutrition market. Some of the major companies having a good presence across the North American region include Abbott, Nestle, Baxter B Braun, and Danone Nutricia.

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Metabolic Disorders

4.2.2 Increasing Spending on Healthcare by Government & Private Foundations

4.2.3 Growing Aging Population in North American Countries

4.3 Market Restraints

4.3.1 Imprecise Perception about Clinical Nutrition

4.3.2 Reduction in Birth Rates

4.4 Porter’s Five Forces Analysis

5.1 By Route of Administration

5.1.1 Oral & Enteral

5.1.2 Parenteral

5.2 By Application

5.2.1 Nutritional Support in Malnutrition

5.2.2 Nutritional Support in Metabolic Disorders

5.2.3 Nutritional Support in Gastrointestinal Diseases

5.2.4 Nutritional Support in Neurological Diseases

5.2.5 Nutritional Support in Cancer

5.2.6 Nutritional Support in Others

5.3 By End-user

5.3.1 Pediatric

5.3.2 Adult

5.4 Geography

5.4.1 North America US Canada Mexico

6.1 Company Profiles

6.1.1 Abbott Laboratories (Abbott Nutrition)

6.1.2 B. Braun Melsungen AG

6.1.3 BASF SE

6.1.4 Baxter

6.1.5 Nestle S.A.

6.1.6 Danone Nutricia

6.1.7 Fresenius Kabi

6.1.8 Perrigo Company PLC

For more information about this report visit

Let’s block ads! (Why?)


Powered by WPeMatico

%d bloggers like this:
Skip to toolbar